FDA — authorised 30 October 1959
- Marketing authorisation holder: ORGANON USA INC
- Status: approved
🇺🇸 Nandrolon Phenylpropionate in United States
FDA authorised Nandrolon Phenylpropionate on 30 October 1959
Marketing authorisations
FDA — authorised 30 October 1959
- Application: NDA011891
- Marketing authorisation holder: ORGANON USA INC
- Local brand name: DURABOLIN
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA
- Application: ANDA087488
- Marketing authorisation holder: WATSON LABS
- Local brand name: NANDROLONE PHENPROPIONATE
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA
- Application: ANDA086386
- Marketing authorisation holder: WATSON LABS
- Local brand name: NANDROLONE PHENPROPIONATE
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA
- Application: ANDA089297
- Marketing authorisation holder: QUAD PHARMS
- Local brand name: NANDROLONE PHENPROPIONATE
- Indication: Injectable — Injection
- Status: approved
FDA
- Application: ANDA089298
- Marketing authorisation holder: QUAD PHARMS
- Local brand name: NANDROLONE PHENPROPIONATE
- Indication: Injectable — Injection
- Status: approved
Nandrolon Phenylpropionate in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Bone approved in United States
Frequently asked questions
Is Nandrolon Phenylpropionate approved in United States?
Yes. FDA authorised it on 30 October 1959; FDA authorised it on 30 October 1959; FDA has authorised it.
Who is the marketing authorisation holder for Nandrolon Phenylpropionate in United States?
ORGANON USA INC holds the US marketing authorisation.